IRIS
CENTONZE, DIEGO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 143.471
AS - Asia 19.260
EU - Europa 13.569
SA - Sud America 2.474
AF - Africa 223
Continente sconosciuto - Info sul continente non disponibili 62
OC - Oceania 55
AN - Antartide 1
Totale 179.115
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 142.993
SG - Singapore 9.009
CN - Cina 3.446
IT - Italia 2.531
BR - Brasile 2.084
HK - Hong Kong 1.917
RU - Federazione Russa 1.895
UA - Ucraina 1.818
DE - Germania 1.681
KR - Corea 1.544
IE - Irlanda 1.468
VN - Vietnam 1.263
FR - Francia 832
GB - Regno Unito 807
SE - Svezia 672
BD - Bangladesh 574
FI - Finlandia 544
JP - Giappone 469
PL - Polonia 369
NL - Olanda 319
CA - Canada 263
IN - India 248
AR - Argentina 153
ID - Indonesia 127
ES - Italia 102
TR - Turchia 100
MX - Messico 99
IQ - Iraq 98
ZA - Sudafrica 86
AT - Austria 85
BE - Belgio 64
CZ - Repubblica Ceca 63
EC - Ecuador 56
UZ - Uzbekistan 52
EU - Europa 50
RO - Romania 48
AU - Australia 47
CL - Cile 47
IR - Iran 39
PH - Filippine 38
BG - Bulgaria 35
SA - Arabia Saudita 35
MA - Marocco 34
MY - Malesia 34
PY - Paraguay 34
LT - Lituania 32
CH - Svizzera 29
CO - Colombia 29
PK - Pakistan 27
GR - Grecia 24
AE - Emirati Arabi Uniti 23
KE - Kenya 23
DK - Danimarca 22
KG - Kirghizistan 22
UY - Uruguay 21
VE - Venezuela 21
JM - Giamaica 20
NP - Nepal 20
PE - Perù 20
TN - Tunisia 20
EG - Egitto 19
PT - Portogallo 19
IL - Israele 18
AL - Albania 17
JO - Giordania 17
HR - Croazia 16
KZ - Kazakistan 16
TW - Taiwan 16
DM - Dominica 15
DZ - Algeria 15
TH - Thailandia 15
AZ - Azerbaigian 13
CR - Costa Rica 13
DO - Repubblica Dominicana 13
RS - Serbia 13
HN - Honduras 12
OM - Oman 12
LB - Libano 11
NO - Norvegia 11
SI - Slovenia 9
TT - Trinidad e Tobago 9
BO - Bolivia 8
HU - Ungheria 8
A2 - ???statistics.table.value.countryCode.A2??? 7
BH - Bahrain 7
CY - Cipro 7
KH - Cambogia 7
LV - Lettonia 7
BN - Brunei Darussalam 6
GT - Guatemala 6
NG - Nigeria 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
PA - Panama 6
SK - Slovacchia (Repubblica Slovacca) 6
MN - Mongolia 5
MT - Malta 5
SV - El Salvador 5
AM - Armenia 4
CI - Costa d'Avorio 4
Totale 179.040
Salva come PNG Salva come JPEG
Città #
Woodbridge 39.298
Wilmington 37.935
Houston 32.859
Fairfield 4.469
Singapore 4.051
Ann Arbor 3.272
Ashburn 2.538
Hong Kong 1.880
San Jose 1.879
Seattle 1.793
Chandler 1.739
Jacksonville 1.597
Cambridge 1.529
Dublin 1.418
Beijing 1.105
Medford 1.024
New York 724
The Dalles 713
Santa Clara 664
Rome 574
Dearborn 561
Lawrence 486
Los Angeles 465
Ho Chi Minh City 401
Tokyo 397
Council Bluffs 388
Dallas 384
Buffalo 364
Zhengzhou 351
Hanoi 277
Hangzhou 276
Kraków 273
Moscow 259
Lauterbourg 245
Mülheim 241
San Diego 238
São Paulo 214
Milan 212
Menlo Park 199
Norwalk 173
Munich 158
Orem 150
London 142
Chicago 128
Redwood City 107
Helsinki 102
Shanghai 98
Guangzhou 96
San Mateo 86
Lappeenranta 85
Frankfurt am Main 84
Redondo Beach 82
Nuremberg 81
Mountain View 80
North Bergen 80
Montreal 79
Chennai 78
University Park 78
Jakarta 74
Toronto 74
Falls Church 69
Brooklyn 68
Rio de Janeiro 65
Seoul 65
Verona 63
Warsaw 63
Naples 60
Saint Petersburg 60
Atlanta 59
San Francisco 58
Detroit 57
Amsterdam 56
Brussels 56
Hefei 56
Nanjing 55
Palo Alto 55
Johannesburg 50
Philadelphia 50
Salt Lake City 50
Belo Horizonte 49
Boardman 49
Denver 47
Manchester 47
Brno 46
Colorado Springs 46
Columbus 46
Haiphong 45
Mcallen 45
Stockholm 44
Phoenix 43
Da Nang 41
Brasília 39
Tashkent 37
Vienna 37
Kunming 36
Paris 36
Boston 35
Florence 34
Mumbai 33
Poplar 33
Totale 151.390
Salva come PNG Salva come JPEG
Nome #
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression 726
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis 664
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 615
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 608
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 606
TRPV1 channels facilitate glutamate transmission in the striatum 599
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 594
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 591
Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma 587
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 579
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? 576
Neurophysiology of synaptic functioning in multiple sclerosis 573
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 551
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 549
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 528
KFLC Index utility in multiple sclerosis diagnosis: Further confirmation 526
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 525
miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation 522
The cross-cultural adaptation and psychometric validation of the MSSS-88 for use in Italian patients with multiple sclerosis 521
Connectivity Between Posterior Parietal Cortex and Ipsilateral Motor Cortex Is Altered in Schizophrenia 518
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 517
K Index in cerebrospinal fluid: a valid tool in multiple sclerosis diagnosis 516
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 515
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 513
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients 513
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 511
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 509
Effects of postural exercises in patients with Parkinson's disease and Pisa syndrome: A pilot study 508
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 507
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 506
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy 503
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 503
Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes 500
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 496
TRPV1 channels regulate cortical excitability in humans 489
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 485
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 485
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 481
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 480
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads 479
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 479
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 478
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 477
Subclinical central inflammation is risk for RIS and CIS conversion to MS 477
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis 475
Muscarinic IPSPs in rat striatal cholinergic interneurones 474
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 474
Abnormal brain lateralization and connectivity in schizophrenia 474
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 474
Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes 472
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 472
Treatment decisions for patients with active multiple sclerosis 471
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells 470
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 470
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 469
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 469
Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans 468
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 468
Synaptic transmission in the striatum: from plasticity to neurodegeneration 468
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis 468
Gabaergic and glutamatergic synaptic transmissions are altered after cuprizone exposure: implication for schizophrenia and demyelinating diseases 467
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 467
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 466
A Substrate Trapping Mutant Form of Striatal-Enriched Protein Tyrosine Phosphatase Prevents Amphetamine-Induced Stereotypies and Long-Term Potentiation in the Striatum 465
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 464
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 464
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis 463
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 462
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment 462
Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis 462
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 461
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 461
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 461
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 460
Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis 459
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis 459
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 459
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 459
Disability in multiple sclerosis: When synaptic long-term potentiation fails 459
D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801 458
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis 458
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 457
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 457
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 457
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis 457
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 457
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 457
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 455
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis 454
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes 454
Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis 454
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis 453
Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management 452
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 452
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 451
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 451
Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis 449
Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis 449
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 449
Transcranial direct current stimulation (tdcs) does not produce acute urodynamic changes 449
Totale 49.331
Salva come PNG Salva come JPEG
Categoria #
all - tutte 423.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 423.661
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021331 0 0 0 0 0 0 0 0 0 0 0 331
2021/20224.728 193 335 187 239 107 671 203 201 427 541 219 1.405
2022/20235.738 745 376 290 610 344 1.499 546 291 395 41 446 155
2023/20241.872 259 72 135 110 161 433 156 98 34 64 33 317
2024/202513.492 356 2.704 1.245 654 477 1.041 1.003 507 1.040 1.084 1.894 1.487
2025/202620.254 1.509 1.076 2.284 1.299 2.034 617 2.476 2.484 2.393 2.015 1.163 904
Totale 180.935